Clinical Trial

An Observational Study to Learn About Velsipity After Long Term Use in Patients With Ulcerative Colitis

Name: An Observational Study to Learn About Velsipity After Long Term Use in Patients With Ulcerative Colitis — clinical trial record (NCT07459686)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

A study to assess the safety and effectiveness of Velsipity Tablets 2 mg during long-term treatment (up to a maximum of 52 weeks) in patients with ulcerative colitis under actual medical practice.

Protocol Amendment History 1 change

critical Recruitment opened 2026-05-19

Trial Details

NCT Number	NCT07459686
Lead Sponsor	Pfizer
Conditions	Ulcerative Colitis (UC)
Enrollment	553 participants
Start Date	2026-04-27
Primary Completion	2029-01-29 (estimated)
Study Completion	2029-01-29 (estimated)
Updated on ClinicalTrials.gov	2026-05-18